Structure and dynamics of a functional cavity in the HIV-1 Envelope, and its role in conformational changes required for infection
Structure and dynamics of a functional cavity in the HIV-1 Envelope, and its role in conformational changes required for infection
批准号:
9927124
负责人:
Priyamvada Acharya
金额:
$22.63万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-01-09 至 2021-12-31
关键词:
AdoptedAffectAffinityAlgorithmsAnimal ModelAntibodiesAtopobium vaginaeBindingBinding SitesBiological AssayCD4 AntigensCase StudyCell membraneCell surfaceCollaborationsComplementComplexCryoelectron MicroscopyCrystallizationDataData CollectionDrug DesignEvolutionGlycoproteinsGoalsGrantHIV Envelope Protein gp120HIV InfectionsHIV-1HandHumanInfectionInvestigationLabelLettersLigandsMeasuresMechanicsMediatingMembrane FusionMethodsMicroscopeMolecularMolecular ConformationMolecular ProbesMovementPeptidesPeripheral Blood Mononuclear CellPharmaceutical PreparationsPlayPropertyPublishingResolutionRoleSpecimenStructureTechnologyTenofovirVaccine DesignVariantVirusWritinganalogcervicovaginalcomputerized data processingconformational conversionexpectationexperimental studyflexibilityimprovedinhibitor/antagonistinnovationinsightmimeticsmonomerprotein structurereceptor bindingsimulationtooltrendvaginal microbicide
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Structure and dynamics of a functional cavity in the HIV-1 Envelope, and its role in conformational changes
required for infection
Channels and cavities in protein structures often play an important role in modulating structure, function and
dynamics. The HIV-1 Envelope (Env) glycoprotein, a conformational machine that utilizes receptor binding
mediated conformational changes to effect virus and host cell membrane fusion, is riddled with cavities and
channels. A highly conserved cavity – called the Phe43 cavity - engages the Phe43 residue of receptor CD4
and is critical for CD4-induced Env conformational transitions. The Phe43 cavity is also the binding site of
broad and potent antibodies, drugs and peptide inhibitors of HIV-1 entry. The CD4-mimetic miniprotein M48U1,
effects broad and potent HIV-1 neutralization, binds HIV-1 gp120 with pM affinity, showed efficacy as a vaginal
microbicide in animal models, and more recently, was shown to synergize with the drug Tenofovir to inhibit HIV
infection in activated PBMCs and human cervicovaginal histocultures. M48U1 inserts a methoxy cyclohexyl
moiety to fill the Phe43 cavity. M48U1 and its analogs are the only class of ligands that reach deep into the
Phe43 cavity, a property that makes them valuable tools for probing the structure of a deep, otherwise not
easily accessible cavity.We have previously utilized M48U1 and its analogs to probe the structure of the Phe-
43 cavity in gp120 monomers. High resolution structures of M48U1 bound to HIV-1 Env gp120 revealed ligand
flexibility, and the ability to fit within and adapt to the Phe43 cavities of diverse HIV-1 isolates with minimal
perturbations of the cavity structure are key determinants of activity.
In this grant we propose to explore the structure of the Phe43 cavity in the closed HIV-1 Env trimer using
M48U1 as a molecular probe. The innovation in this grant derives from our use of M48U1 and its analogs as
molecular probes of the Phe43 cavity, from the advances in cryo-EM technology that include improved
specimen vitrification methods, improved microscope hardware, automated methods for high-throughput data
collection, and advanced algorithms for data processing. These advances have recently allowed us to
establish a rapid pipeline for determining high resolution structures of HIV-1 Env complexes. The scientific
premise of this grant is that the Phe43 cavity is a critical functional component in HIV-1 Env, central to the
activity of the CD4 receptor and many broad and potent antibodies and drugs. M48U1 is an exceptionally
effective HIV-1 entry inhibitor, and one of the only ligands that fills the entire Phe-43 cavity. Exploring the
structures of HIV-1 Env when bound to M48U1 will provide insights into the structure and the conformational
constraints on the cavity in the closed state of the Env.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Effect of natural and engineered variations on structure and biophysics of SARS-CoV-2 spike
-
批准号:10558637
-
项目类别:
-
资助金额:$76.25万
-
财政年份:2022
-
负责人:Priyamvada Acharya
-
依托单位:
Administrative Core
-
批准号:10643907
-
项目类别:
-
资助金额:$47.26万
-
财政年份:2022
-
负责人:Priyamvada Acharya
-
依托单位:
Project 3 - Dynamics of latent HIV-1 reservoirs: High resolution antigenic mapping and strategies to block rebound
-
批准号:10506669
-
项目类别:
-
资助金额:$87.01万
-
财政年份:2022
-
负责人:Priyamvada Acharya
-
依托单位:
Duke Center for HIV Structural Biology
-
批准号:10643906
-
项目类别:
-
资助金额:$548.85万
-
财政年份:2022
-
负责人:Priyamvada Acharya
-
依托单位:
Core 1 - Structural Biology Core
-
批准号:10506664
-
项目类别:
-
资助金额:$89.03万
-
财政年份:2022
-
负责人:Priyamvada Acharya
-
依托单位:
Administrative Core
-
批准号:10506662
-
项目类别:
-
资助金额:$38.67万
-
财政年份:2022
-
负责人:Priyamvada Acharya
-
依托单位:
Dissecting the mechanisms of HIV resistance in vivo to broadly neutralizing antibodies
-
批准号:10458981
-
项目类别:
-
资助金额:$150.46万
-
财政年份:2022
-
负责人:Priyamvada Acharya
-
依托单位:
Duke Center for HIV Structural Biology
-
批准号:10506661
-
项目类别:
-
资助金额:$550.51万
-
财政年份:2022
-
负责人:Priyamvada Acharya
-
依托单位:
Core 1 - Structural Biology Core
-
批准号:10643911
-
项目类别:
-
资助金额:$111.15万
-
财政年份:2022
-
负责人:Priyamvada Acharya
-
依托单位:
Dissecting the mechanisms of HIV resistance in vivo to broadly neutralizing antibodies
-
批准号:10680388
-
项目类别:
-
资助金额:$155.21万
-
财政年份:2022
-
负责人:Priyamvada Acharya
-
依托单位:
Effect of natural and engineered variations on structure and biophysics of SARS-CoV-2 spike
-
批准号:10453964
-
项目类别:
-
资助金额:$76.25万
-
财政年份:2022
-
负责人:Priyamvada Acharya
-
依托单位:
Project 3 - Dynamics of latent HIV-1 reservoirs: High resolution antigenic mapping and strategies to block rebound
-
批准号:10643926
-
项目类别:
-
资助金额:$118.89万
-
财政年份:2022
-
负责人:Priyamvada Acharya
-
依托单位:
Structural characterization of Fab-dimerized glycan-reactive antibodies that neutralize HIV-1
-
批准号:10490900
-
项目类别:
-
资助金额:$69.54万
-
财政年份:2021
-
负责人:Priyamvada Acharya
-
依托单位:
Structural characterization of Fab-dimerized glycan-reactive antibodies that neutralize HIV-1
-
批准号:10403172
-
项目类别:
-
资助金额:$70.49万
-
财政年份:2021
-
负责人:Priyamvada Acharya
-
依托单位:
Structural characterization of Fab-dimerized glycan-reactive antibodies that neutralize HIV-1
-
批准号:10682532
-
项目类别:
-
资助金额:$68.34万
-
财政年份:2021
-
负责人:Priyamvada Acharya
-
依托单位:
Targeting early metastable intermediates of the SARS-CoV-2 spike for vaccine and therapeutics development
-
批准号:10265660
-
项目类别:
-
资助金额:$77.13万
-
财政年份:2020
-
负责人:Priyamvada Acharya
-
依托单位:
Structure and dynamics of a functional cavity in the HIV-1 Envelope, and its role in conformational changes required for infection
-
批准号:10083703
-
项目类别:
-
资助金额:$20.13万
-
财政年份:2020
-
负责人:Priyamvada Acharya
-
依托单位:
Structures of initial CD4 engagement with pre-fusion, closed HIV-1 Envelope trimer and early CD4-induced conformational changes required for infection
-
批准号:10552588
-
项目类别:
-
资助金额:$77.08万
-
财政年份:2019
-
负责人:Priyamvada Acharya
-
依托单位:
Structures of initial CD4 engagement with pre-fusion, closed HIV-1 Envelope trimer and early CD4-induced conformational changes required for infection
-
批准号:10090565
-
项目类别:
-
资助金额:$73.92万
-
财政年份:2019
-
负责人:Priyamvada Acharya
-
依托单位:
Structures of initial CD4 engagement with pre-fusion, closed HIV-1 Envelope trimer and early CD4-induced conformational changes required for infection
-
批准号:10331729
-
项目类别:
-
资助金额:$77.97万
-
财政年份:2019
-
负责人:Priyamvada Acharya
-
依托单位:
海外基金